Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|1|2|137-147

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.1, Iss.2, 2001-07, pp. : 137-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3248-3256

Bentham Science Publishers

Access to resources Recommend Favorite

From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy

By  

Current Gene Therapy, Vol. 3, Iss. 4, 2003-01 ,pp. : 281-304

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Recombinant AAV-Mediated Gene Therapy for Lung Diseases

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 361-366

Bentham Science Publishers

Access to resources Recommend Favorite

MDR1 gene therapy: successful transduction feasible

By  

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Protein Transduction Domains and their Utility in Gene Therapy

By  

Current Gene Therapy, Vol. 3, Iss. 5, 2003-10 ,pp. : 486-494

Bentham Science Publishers

Access to resources Recommend Favorite